Provider
Spevigo - Commercial
Program effective Date: Oct 01, 2024
Documents & Forms Results
Displaying 1221 - 1230 of 3111 results
Provider
Angiotensin II Receptor Antagonists (ARBs), Renin Inhibitors and Combinations - Medicaid
Program effective Date: Oct 01, 2024
Provider
Benign Prostatic Hypertrophy (BPH) - Medicaid
Program effective Date: Oct 01, 2024
Provider
Proton Pump Inhibitors (PPI's) - Commercial
Program effective Date: Oct 01, 2024
Provider
Xolair® (omalizumab) - Commercial
Program effective Date: Oct 01, 2024
Provider
Neurotrophic Keratitis - Medicaid
Program effective Date: Oct 01, 2024
Provider
Neurotrophic Keratitis - Commercial
Program effective Date: Oct 01, 2024
Provider
Proton Pump Inhibitors (PPI's) - Medicaid
Program effective Date: Oct 01, 2024
Provider
Angiotensin II Receptor Antagonists (ARBs), Renin Inhibitors and Combinations - Commercial
Program effective Date: Oct 01, 2024
Provider
QP73-24 Prime Therapeutics/Magellan Rx Management (medical pharmacy solutions program) to become “Prime Therapeutics Management”
Program effective Date: Sep 25, 2024